Cutaneous: Melanoma Regimens

DISEASE: Cutaneous: Melanoma

Select a REGIMEN:

DISEASE: Cutaneous: Melanoma

REGIMEN: DBPT

DACARBAZINE

CISPLATIN [CDDP] 25 mg/m2 per day IV...D1-3
q 3 weeks

CARMUSTINE [BCNU] 150 mg/m2 IV...D1
q 6 weeks Caution: Monitor cumulative dose (pulmonary and marrow toxicity)

TAMOXIFEN [TAM] 10 mg PO...daily
BID

CYCLE: None
REFER: Skeel RT: Handbook of Cancer Chemotherapy, 3rd Ed. Little, Brown & Co. 1991; 256.

DISEASE: Cutaneous: Melanoma

REGIMEN: DTIC1

DACARBAZINE

CYCLE: 21 days
REFER: DeVita VT Jr, et al: Cancer Principles and Practice of Oncology 3rd Ed. J.B.Lippincott Co. 1989; 1522.

DISEASE: Cutaneous: Melanoma

REGIMEN: DTIC2

DACARBAZINE

CYCLE: 21-28 days
REFER: DeVita VT Jr, et al: Cancer Principles and Practice of Oncology 3rd Ed. J.B.Lippincott Co. 1989; 1637.

DISEASE: Cutaneous: Melanoma

REGIMEN: VDP

VINBLASTINE

DACARBAZINE [DTIC] 150 mg/m2 per day IV...D1-10

CISPLATIN [CDDP] 75 mg/m2 IV...D5

CYCLE: 21-28 days
REFER: Nathanson L: Melanomas ... In: Skeel RT, ed. Handbook of Cancer Chemotherapy, 3rd Ed. Little, Brown & Co. 1991; 256.

Medicine OnLine and UltiTech have no liability for content or goods on the Internet except as set forth in the Terms and Conditions of service.

Please read the Disclaimer of Warranties before using information contained in this section.